Incorrect diagnosis of myotonic dystrophy and its potential consequences revealed by subsequent direct genetic analysis.

Incorrect diagnosis of myotonic dystrophy and its potential consequences revealed by subsequent direct genetic analysis.

Detalhes bibliográficos
Main Authors:	Barnes, P, Hilton-Jones, D, Norbury, G, Roberts, A, Huson, S
Formato:	Journal article
Idioma:	English
Publicado em:	1994

Registos relacionados

Molecular genetics of myotonic dystrophy.
Por: Barnes, P, et al.
Publicado em: (1993)

The myotonic dystrophies: diagnosis and management.
Por: Turner, C, et al.
Publicado em: (2010)

Myotonic dystrophy: diagnosis, management and new therapies.
Por: Turner, C, et al.
Publicado em: (2014)

Myotonic dystrophy--forgotten aspects of an often neglected condition.
Por: Hilton-Jones, D
Publicado em: (1997)

Myotonic dystrophy: practical issues relating to assessment of strength.
Por: Whittaker, R, et al.
Publicado em: (2006)

Molecular genetics of congenital myotonic dystrophy
Por: Stella Lanni, et al.
Publicado em: (2019-12-01)

Myotonic dystrophy: genetics and clinical polymorphism
Por: Ekaterina O. Ivanova, et al.
Publicado em: (2019-03-01)

Clinical and molecular aspects of the myotonic dystrophies: a review.
Por: Machuca-Tzili, L, et al.
Publicado em: (2005)

Three cases of androgen-dependent disease associated with myotonic dystrophy.
Por: Cooper, S, et al.
Publicado em: (2003)

Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
Por: Talbot, K, et al.
Publicado em: (2003)

Positive effect of modafinil on daytime somnolence on patients with Myotonic Dystrophy
Por: Talbot, K, et al.
Publicado em: (2002)

Congenital Myotonic Dystrophy
Por: J Gordon Millichap
Publicado em: (1987-09-01)

Modafinil for excessive daytime sleepiness in myotonic dystrophy type 1--the patients' perspective.
Por: Hilton-Jones, D, et al.
Publicado em: (2012)

Modafinil for excessive daytime sleepiness in myotonic dystrophy type 1 - The patients' perspective
Por: Hilton-Jones, D, et al.
Publicado em: (2012)

MRI in Congenital Myotonic Dystrophy
Por: J Gordon Millichap
Publicado em: (1992-10-01)

Cerebral Hypoperfusion in Myotonic Dystrophy
Por: J Gordon Millichap
Publicado em: (1993-10-01)

Myotonic dystrophy type 2
Por: G. E. Rudenskaya, et al.
Publicado em: (2017-02-01)

Cardiac involvement in myotonic dystrophy
Por: Koroush Khalighi, et al.
Publicado em: (2015-02-01)

Ophthalmological findings in myotonic dystrophy
Por: Maddalena De Bernardo, et al.

Desflurane anaesthesia in myotonic dystrophy
Por: Ranju Gandhi, et al.
Publicado em: (2011-01-01)

Myotonic Dystrophy: An Anaesthetic Dilemma
Por: N Gupta, et al.
Publicado em: (2009-01-01)

A randomised controlled trial of modafinil for treatment of daytime somnolence in myotonic dystrophy
Por: Talbot, K, et al.
Publicado em: (2003)

Behavioral Disorders with Antisocial Personality and the Consequences of Incorrect Diagnosis
Por: Barbara Katarzyna Cygan
Publicado em: (2021-12-01)

Pattern retinal dystrophy in a case of myotonic dystrophy
Por: Chahveer Singh Bindra, et al.
Publicado em: (2023-01-01)

Marathoning with myotonic dystrophy type 2 (proximal myotonic myopathy) and leukopenia
Por: Josef Finsterer, et al.
Publicado em: (2017-04-01)

Alternative isoform regulation in myotonic dystrophy
Por: Wang, Eric T. (Eric Tzy-shi)
Publicado em: (2012)

Myotonic Dystrophy: Severity and Maternal Age
Por: J Gordon Millichap
Publicado em: (1992-06-01)

Congenital Myotonic Dystrophy and Pleural Effusion
Por: J Gordon Millichap
Publicado em: (1988-09-01)

Congenital Myotonic Dystrophy in the Neonatal Period -
Por: Barbora Červenková
Publicado em: (2023-06-01)

Anesthesia for a Patient with Myotonic Dystrophy
Por: Dilek Kalaycı, et al.
Publicado em: (2016-09-01)

Myotonic Dystrophy—A Progeroid Disease?
Por: Peter Meinke, et al.
Publicado em: (2018-07-01)

CONGENITAL MYOTONIC DYSTROPHY – CASE REPORT
Por: David Neubauer, et al.
Publicado em: (2001-07-01)

Core Clinical Phenotypes in Myotonic Dystrophies
Por: Stephan Wenninger, et al.
Publicado em: (2018-05-01)

Peptide-conjugated PMOs for the treatment of myotonic dystrophy
Por: Stoodley, J, et al.
Publicado em: (2022)

Antenatal Indomethacin Treatment for Congenital Myotonic Dystrophy
Por: Kyohei Yamaguchi, et al.
Publicado em: (2019-01-01)

Cardiac manifestations in myotonic dystrophy type 1
Por: A. G. Klementieva, et al.
Publicado em: (2024-09-01)

Cutaneous findings in myotonic dystrophyCapsule Summary
Por: Ha Eun Kong, MD, PhD, et al.
Publicado em: (2022-06-01)

Cardiac Involvement and Arrhythmias Associated with Myotonic Dystrophy
Por: Daniel McBride, et al.
Publicado em: (2022-04-01)

Aberrant Myokine Signaling in Congenital Myotonic Dystrophy
Por: Masayuki Nakamori, et al.
Publicado em: (2017-10-01)

Limited orthodontic treatment in myotonic dystrophy II
Por: Aurelia Magdalena Enache, et al.
Publicado em: (2017-12-01)